KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Non-Current Deffered Revenue (2016 - 2018)

CareDx (CDNA) has disclosed Non-Current Deffered Revenue for 6 consecutive years, with $691000.0 as the latest value for Q4 2018.

  • Quarterly Non-Current Deffered Revenue fell 24.32% to $691000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $691000.0 through Dec 2018, down 24.32% year-over-year, with the annual reading at $691000.0 for FY2018, 24.32% down from the prior year.
  • Non-Current Deffered Revenue hit $691000.0 in Q4 2018 for CareDx, down from $701000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $1.8 million in Q2 2014 to a low of $471000.0 in Q4 2014.
  • Historically, Non-Current Deffered Revenue has averaged $1.2 million across 5 years, with a median of $1.3 million in 2016.
  • Biggest five-year swings in Non-Current Deffered Revenue: crashed 75.01% in 2014 and later soared 202.76% in 2015.
  • Year by year, Non-Current Deffered Revenue stood at $471000.0 in 2014, then skyrocketed by 202.76% to $1.4 million in 2015, then decreased by 8.77% to $1.3 million in 2016, then dropped by 29.82% to $913000.0 in 2017, then dropped by 24.32% to $691000.0 in 2018.
  • Business Quant data shows Non-Current Deffered Revenue for CDNA at $691000.0 in Q4 2018, $701000.0 in Q3 2018, and $711000.0 in Q2 2018.